Search results for "Personalized therapy"

showing 4 items of 14 documents

CIMT 2019: report on the 17th Annual Meeting of the Association for Cancer Immunotherapy

2019

The 17th Annual Meeting of the Association for Cancer Immunotherapy (CIMT), Europe`s cancer immunotherapy meeting, took place in Mainz, Germany from 21 to 23 May, 2019. Recent advancements in cance...

Oncologymedicine.medical_specialtyCombination therapymedicine.medical_treatment030231 tropical medicineImmunologyMeeting ReportCancer Vaccinescombination therapyCell therapy03 medical and health sciences0302 clinical medicineCancer immunotherapyNeoplasmsInternal medicineTumor MicroenvironmentHumansImmunology and AllergyMedicine030212 general & internal medicinetumor vaccinationPersonalized therapypersonalized therapyPharmacologyTumor microenvironmentcancer immunotherapybusiness.industryCIMTcellular therapyCongresses as Topiccheckpoint blockadeImmunotherapybusinessHuman Vaccines & Immunotherapeutics
researchProduct

Treatment of clinically localized renal tumors in the elderly

2011

There are several options for treating clinically localized renal tumors in the elderly, ranging from active surveillance to radical nephrectomy. Reduced renal function is associated with increased cardiovascular mortality, so maintaining renal function is of the utmost importance. Personalized therapy should be based on tumor location, comorbidities and general health status rather than tumor size and patient age.

medicine.medical_specialtyTumor sizebusiness.industryUrologymedicine.medical_treatmentUrologyRenal functionurologic and male genital diseasesmedicine.diseaseNephrectomymedicineGeneral healthTumor locationPersonalized therapybusinessKidney cancerCardiovascular mortalityNature Reviews Urology
researchProduct

The Value of Liquid Biopsies for Guiding Therapy Decisions in Non-small Cell Lung Cancer

2019

personalized therapysyöpähoidotEGFRprecision medicinebiopsiaDNActDNAdiagnostiikkata3111ta3122verenkiertoNSCLCkeuhkosyöpäsyöpäsolutmarkkeritcancerFrontiers in Oncology
researchProduct

Radiolabeling of Nanoparticles and Polymers for PET Imaging

2014

Nanomedicine has become an emerging field in imaging and therapy of malignancies. Nanodimensional drug delivery systems have already been used in the clinic, as carriers for sensitive chemotherapeutics or highly toxic substances. In addition, those nanodimensional structures are further able to carry and deliver radionuclides. In the development process, non-invasive imaging by means of positron emission tomography (PET) represents an ideal tool for investigations of pharmacological profiles and to find the optimal nanodimensional architecture of the aimed-at drug delivery system. Furthermore, in a personalized therapy approach, molecular imaging modalities are essential for patient screeni…

radiolabelingmedicine.medical_specialtyPharmaceutical ScienceNanoparticlelcsh:Medicinelcsh:RS1-441NanotechnologyReviewlcsh:Pharmacy and materia medicaDrug DiscoverymedicineMedical physicsPersonalized therapypolymersmedicine.diagnostic_testbusiness.industrylcsh:RPositron emittersimagingPet imagingnanomedicinepositron emitterPETPositron emission tomographyDrug deliverydrug deliveryMolecular MedicineNanomedicinenanoparticlesMolecular imagingbusinessPharmaceuticals
researchProduct